Gene-encoded TRIM21 degraders

Gene-encoded TRIM21 degraders has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Nov 4, 2026: “Nanoparticles enable selective protein removal in animals”.

Intervention

1 paper studies it1 findingUpdated Nov 1, 2026

1 new paper in 30 daysSee all 1 papers on gene-encoded TRIM21 degraders

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

1 lab in 1 country

Animals1

What did studies of gene-encoded TRIM21 degraders find?

Studies of gene-encoded TRIM21 degraders measured 1 outcome; the most studied are endogenous protein abundance (1 study).

Endogenous protein abundance

downin animals1

1 study

Gene-encoded TRIM21 degraders decrease endogenous protein abundance (preclinical models).
“systemic administration yielded proof‐of‐concept tumor‐ and brain‐targeted gene delivery, target‐protein depletion in preclinical models”
Animalspreclinical modelsplasmids delivered by targeted lipid–polymer hybrid nanoparticles
Nanoparticles enable selective protein removal in animals
Advanced Functional MaterialsNov 1, 2026

Latest

1 paper in 12 months

Advanced Functional MaterialsNov 4

Nanoparticles enable selective protein removal in animals

Proof-of-concept animal experiments used DNA-carrying particles for tumor- and brain-targeted gene delivery, with encouraging signals in selected cancer and…Proof-of-concept animal experiments used DNA-carrying particles for tumor- and brain-targeted gene delivery, with encouraging signals in selected cancer and neurodegeneration models.

Animal studyInterventions

Paper

Gene-encoded TRIM21 degraders

At a glance

What did studies of gene-encoded TRIM21 degraders find?

Latest

Nanoparticles enable selective protein removal in animals

Related